Tumor–host cell interactions in the bone disease of myeloma

Abstract Multiple myeloma is a hematological malignancy that is associated with the development of a destructive osteolytic bone disease, which is a major cause of morbidity for patients with myeloma. Interactions between myeloma cells and cells of the bone marrow microenvironment promote both tumor...

Full description

Saved in:
Bibliographic Details
Published in:Bone (New York, N.Y.) N.Y.), 2011-01, Vol.48 (1), p.121-128
Main Authors: Fowler, Jessica A, Edwards, Claire M, Croucher, Peter I
Format: Article
Language:English
Subjects:
Bone and Bones - metabolism
Bone and Bones - pathology
Bone Diseases - complications
Bone Diseases - etiology
Bone Diseases - pathology
Bone Marrow - metabolism
Bone Marrow - pathology
Cell Communication
Humans
Multiple Myeloma - complications
Multiple Myeloma - drug therapy
Multiple Myeloma - pathology
Orthopedics
Osteoblasts - metabolism
Osteoblasts - pathology
Osteoclasts - metabolism
Osteoclasts - pathology
Osteogenesis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Multiple myeloma is a hematological malignancy that is associated with the development of a destructive osteolytic bone disease, which is a major cause of morbidity for patients with myeloma. Interactions between myeloma cells and cells of the bone marrow microenvironment promote both tumor growth and survival and bone destruction, and the osteolytic bone disease is now recognized as a contributing component to tumor progression. Since myeloma bone disease is associated with both an increase in osteoclastic bone resorption and a suppression of osteoblastic bone formation, research to date has largely focused upon the role of the osteoclast and osteoblast. However, it is now clear that other cell types within the bone marrow, including cells of the immune system, mesenchymal stem cells and bone marrow stromal cells, can contribute to the development of myeloma bone disease. This review discusses the cellular mechanisms and potential therapeutic targets that have been implicated in myeloma bone disease.
ISSN:8756-3282
1873-2763
DOI:10.1016/j.bone.2010.06.029